Eiry W. Roberts, M.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Neurocrine Biosciences Inc publishes a filing, an earnings call transcript or a press release.
Get NBIX alertsAbout Eiry W. Roberts, M.D.
Neurocrine Biosciences Inc reported in an 8-K filed September 28, 2026 that Eiry W. Roberts, M.D. was appointed Chief Medical Officer, effective September 28, 2026. Neurocrine Biosciences Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Neurocrine Biosciences Inc includes Kevin Gorman (CEO and Board Member), Kyle Gano, Ph.D. (CEO and Board Member), Kyle W. Gano (CEO and Board Member) and 7 others.
“On September 28, 2026, the Board of Directors (the “Board”) of Neurocrine Biosciences, Inc. (the “Company”) appointed Eiry W. Roberts, M.D., to succeed Sanjay Keswani, M.D., as the Company’s Chief Medical Officer, effective September 28, 2026 (the “Transition Date”).”
Affiliation history
-
Current
2026-09-28–present
Company network
Leadership on record at Neurocrine Biosciences Inc
- Kevin Gorman CEO, Board Member
- Kyle Gano, Ph.D. CEO, Board Member
- Kyle W. Gano CEO, Board Member
- Matthew C. Abernethy CFO
- Christine A. Poon Board Member
- Gary A. Lyons Board Member
- George J. Morrow Board Member
- Johanna Mercier Board Member
- Kevin C. Gorman Board Member
- Kevin C. Gorman, Ph.D. Board Member